Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.
Identifieur interne : 000950 ( Main/Corpus ); précédent : 000949; suivant : 000951Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.
Auteurs : Jianpu Chen ; Xiang Wang ; Shutong Zhang ; Bin Lin ; Xiaoqing Wu ; Yanfang Wang ; Xiaoqi Wang ; Ming Yang ; Jianqing Sun ; Yuanliang XieSource :
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [ 1938-2723 ]
English descriptors
- KwdEn :
- Acute Disease (MeSH), Adult (MeSH), Aged (MeSH), Anticoagulants (therapeutic use), Betacoronavirus (pathogenicity), Computed Tomography Angiography (methods), Coronavirus Infections (blood), Coronavirus Infections (complications), Coronavirus Infections (diagnostic imaging), Coronavirus Infections (virology), Female (MeSH), Fibrin Fibrinogen Degradation Products (analysis), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (blood), Pneumonia, Viral (complications), Pneumonia, Viral (diagnostic imaging), Pneumonia, Viral (virology), Pulmonary Artery (anatomy & histology), Pulmonary Artery (diagnostic imaging), Pulmonary Artery (virology), Pulmonary Embolism (blood), Pulmonary Embolism (diagnostic imaging), Pulmonary Embolism (etiology), Pulmonary Embolism (virology), Retrospective Studies (MeSH), Thrombosis (drug therapy), Tomography, X-Ray Computed (methods).
- MESH :
- chemical , analysis : Fibrin Fibrinogen Degradation Products.
- chemical , therapeutic use : Anticoagulants.
- anatomy & histology : Pulmonary Artery.
- blood : Coronavirus Infections, Pneumonia, Viral, Pulmonary Embolism.
- complications : Coronavirus Infections, Pneumonia, Viral.
- diagnostic imaging : Coronavirus Infections, Pneumonia, Viral, Pulmonary Artery, Pulmonary Embolism.
- drug therapy : Thrombosis.
- etiology : Pulmonary Embolism.
- methods : Computed Tomography Angiography, Tomography, X-Ray Computed.
- pathogenicity : Betacoronavirus.
- virology : Coronavirus Infections, Pneumonia, Viral, Pulmonary Artery, Pulmonary Embolism.
- Acute Disease, Adult, Aged, Female, Humans, Male, Middle Aged, Pandemics, Retrospective Studies.
Abstract
The aim of this study was to describe clinical, imaging, and laboratory features of acute pulmonary embolism (APE) in patients with COVID-19 associated pneumonia. Patients with COVID-19 associated pneumonia who underwent a computed tomography pulmonary artery (CTPA) scan for suspected APE were retrospectively studied. Laboratory data and CTPA images were collected. Imaging characteristics were analyzed descriptively. Laboratory data were analyzed and compared between patients with and without APE. A series of 25 COVID-19 patients who underwent CTPA between January 2020 and February 2020 were enrolled. The median D-dimer level founded in these 25 patients was 6.06 μg/mL (interquartile range [IQR] 1.90-14.31 μg/mL). Ten (40%) patients with APE had a significantly higher level of D-dimer (median, 11.07 μg/mL; IQR, 7.12-21.66 vs median, 2.44 μg/mL; IQR, 1.68-8.34, respectively, P = .003), compared with the 15 (60%) patients without APE. No significant differences in other laboratory data were found between patients with and without APE. Among the 10 patients with APE, 6 (60%) had a bilateral pulmonary embolism, while 4 had a unilateral embolism. The thrombus-prone sites were the right lower lobe (70%), the left upper lobe (60%), both upper lobe (40%) and the right middle lobe (20%). The thrombus was partially or completely absorbed after anticoagulant therapy in 3 patients who underwent a follow-up CTPA. Patients with COVID-19 associated pneumonia have a risk of developing APE during the disease. When the D-dimer level abnormally increases in patients with COVID-19 pneumonia, CTPA should be performed to detect and assess the severity of APE.
DOI: 10.1177/1076029620936772
PubMed: 32726134
PubMed Central: PMC7391435
Links to Exploration step
pubmed:32726134Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.</title><author><name sortKey="Chen, Jianpu" sort="Chen, Jianpu" uniqKey="Chen J" first="Jianpu" last="Chen">Jianpu Chen</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xiang" sort="Wang, Xiang" uniqKey="Wang X" first="Xiang" last="Wang">Xiang Wang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Shutong" sort="Zhang, Shutong" uniqKey="Zhang S" first="Shutong" last="Zhang">Shutong Zhang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Bin" sort="Lin, Bin" uniqKey="Lin B" first="Bin" last="Lin">Bin Lin</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wu, Xiaoqing" sort="Wu, Xiaoqing" uniqKey="Wu X" first="Xiaoqing" last="Wu">Xiaoqing Wu</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Yanfang" sort="Wang, Yanfang" uniqKey="Wang Y" first="Yanfang" last="Wang">Yanfang Wang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xiaoqi" sort="Wang, Xiaoqi" uniqKey="Wang X" first="Xiaoqi" last="Wang">Xiaoqi Wang</name><affiliation><nlm:affiliation>Philips Healthcare, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Ming" sort="Yang, Ming" uniqKey="Yang M" first="Ming" last="Yang">Ming Yang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Sun, Jianqing" sort="Sun, Jianqing" uniqKey="Sun J" first="Jianqing" last="Sun">Jianqing Sun</name><affiliation><nlm:affiliation>Philips Healthcare, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xie, Yuanliang" sort="Xie, Yuanliang" uniqKey="Xie Y" first="Yuanliang" last="Xie">Yuanliang Xie</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jan-Dec</date><idno type="RBID">pubmed:32726134</idno><idno type="pmid">32726134</idno><idno type="doi">10.1177/1076029620936772</idno><idno type="pmc">PMC7391435</idno><idno type="wicri:Area/Main/Corpus">000950</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000950</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.</title><author><name sortKey="Chen, Jianpu" sort="Chen, Jianpu" uniqKey="Chen J" first="Jianpu" last="Chen">Jianpu Chen</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xiang" sort="Wang, Xiang" uniqKey="Wang X" first="Xiang" last="Wang">Xiang Wang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Shutong" sort="Zhang, Shutong" uniqKey="Zhang S" first="Shutong" last="Zhang">Shutong Zhang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Bin" sort="Lin, Bin" uniqKey="Lin B" first="Bin" last="Lin">Bin Lin</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wu, Xiaoqing" sort="Wu, Xiaoqing" uniqKey="Wu X" first="Xiaoqing" last="Wu">Xiaoqing Wu</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Yanfang" sort="Wang, Yanfang" uniqKey="Wang Y" first="Yanfang" last="Wang">Yanfang Wang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xiaoqi" sort="Wang, Xiaoqi" uniqKey="Wang X" first="Xiaoqi" last="Wang">Xiaoqi Wang</name><affiliation><nlm:affiliation>Philips Healthcare, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Ming" sort="Yang, Ming" uniqKey="Yang M" first="Ming" last="Yang">Ming Yang</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Sun, Jianqing" sort="Sun, Jianqing" uniqKey="Sun J" first="Jianqing" last="Sun">Jianqing Sun</name><affiliation><nlm:affiliation>Philips Healthcare, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xie, Yuanliang" sort="Xie, Yuanliang" uniqKey="Xie Y" first="Yuanliang" last="Xie">Yuanliang Xie</name><affiliation><nlm:affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis</title><idno type="eISSN">1938-2723</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Anticoagulants (therapeutic use)</term><term>Betacoronavirus (pathogenicity)</term><term>Computed Tomography Angiography (methods)</term><term>Coronavirus Infections (blood)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (diagnostic imaging)</term><term>Coronavirus Infections (virology)</term><term>Female (MeSH)</term><term>Fibrin Fibrinogen Degradation Products (analysis)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (blood)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (diagnostic imaging)</term><term>Pneumonia, Viral (virology)</term><term>Pulmonary Artery (anatomy & histology)</term><term>Pulmonary Artery (diagnostic imaging)</term><term>Pulmonary Artery (virology)</term><term>Pulmonary Embolism (blood)</term><term>Pulmonary Embolism (diagnostic imaging)</term><term>Pulmonary Embolism (etiology)</term><term>Pulmonary Embolism (virology)</term><term>Retrospective Studies (MeSH)</term><term>Thrombosis (drug therapy)</term><term>Tomography, X-Ray Computed (methods)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Fibrin Fibrinogen Degradation Products</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term></keywords><keywords scheme="MESH" qualifier="anatomy & histology" xml:lang="en"><term>Pulmonary Artery</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Pulmonary Embolism</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Pulmonary Artery</term><term>Pulmonary Embolism</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Thrombosis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pulmonary Embolism</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Computed Tomography Angiography</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Pulmonary Artery</term><term>Pulmonary Embolism</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to describe clinical, imaging, and laboratory features of acute pulmonary embolism (APE) in patients with COVID-19 associated pneumonia. Patients with COVID-19 associated pneumonia who underwent a computed tomography pulmonary artery (CTPA) scan for suspected APE were retrospectively studied. Laboratory data and CTPA images were collected. Imaging characteristics were analyzed descriptively. Laboratory data were analyzed and compared between patients with and without APE. A series of 25 COVID-19 patients who underwent CTPA between January 2020 and February 2020 were enrolled. The median D-dimer level founded in these 25 patients was 6.06 μg/mL (interquartile range [IQR] 1.90-14.31 μg/mL). Ten (40%) patients with APE had a significantly higher level of D-dimer (median, 11.07 μg/mL; IQR, 7.12-21.66 vs median, 2.44 μg/mL; IQR, 1.68-8.34, respectively, <i>P</i> = .003), compared with the 15 (60%) patients without APE. No significant differences in other laboratory data were found between patients with and without APE. Among the 10 patients with APE, 6 (60%) had a bilateral pulmonary embolism, while 4 had a unilateral embolism. The thrombus-prone sites were the right lower lobe (70%), the left upper lobe (60%), both upper lobe (40%) and the right middle lobe (20%). The thrombus was partially or completely absorbed after anticoagulant therapy in 3 patients who underwent a follow-up CTPA. Patients with COVID-19 associated pneumonia have a risk of developing APE during the disease. When the D-dimer level abnormally increases in patients with COVID-19 pneumonia, CTPA should be performed to detect and assess the severity of APE.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32726134</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1938-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><MedlineDate>2020 Jan-Dec</MedlineDate></PubDate></JournalIssue><Title>Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis</Title><ISOAbbreviation>Clin Appl Thromb Hemost</ISOAbbreviation></Journal><ArticleTitle>Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.</ArticleTitle><Pagination><MedlinePgn>1076029620936772</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1076029620936772</ELocationID><Abstract><AbstractText>The aim of this study was to describe clinical, imaging, and laboratory features of acute pulmonary embolism (APE) in patients with COVID-19 associated pneumonia. Patients with COVID-19 associated pneumonia who underwent a computed tomography pulmonary artery (CTPA) scan for suspected APE were retrospectively studied. Laboratory data and CTPA images were collected. Imaging characteristics were analyzed descriptively. Laboratory data were analyzed and compared between patients with and without APE. A series of 25 COVID-19 patients who underwent CTPA between January 2020 and February 2020 were enrolled. The median D-dimer level founded in these 25 patients was 6.06 μg/mL (interquartile range [IQR] 1.90-14.31 μg/mL). Ten (40%) patients with APE had a significantly higher level of D-dimer (median, 11.07 μg/mL; IQR, 7.12-21.66 vs median, 2.44 μg/mL; IQR, 1.68-8.34, respectively, <i>P</i> = .003), compared with the 15 (60%) patients without APE. No significant differences in other laboratory data were found between patients with and without APE. Among the 10 patients with APE, 6 (60%) had a bilateral pulmonary embolism, while 4 had a unilateral embolism. The thrombus-prone sites were the right lower lobe (70%), the left upper lobe (60%), both upper lobe (40%) and the right middle lobe (20%). The thrombus was partially or completely absorbed after anticoagulant therapy in 3 patients who underwent a follow-up CTPA. Patients with COVID-19 associated pneumonia have a risk of developing APE during the disease. When the D-dimer level abnormally increases in patients with COVID-19 pneumonia, CTPA should be performed to detect and assess the severity of APE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianpu</ForeName><Initials>J</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9117-5249</Identifier><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shutong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanfang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Philips Healthcare, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jianqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Philips Healthcare, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yuanliang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>COVID-19 Investigating and Research Team, Department of Radiology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Jiang'an District, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Appl Thromb Hemost</MedlineTA><NlmUniqueID>9508125</NlmUniqueID><ISSNLinking>1076-0296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="N">Pulmonary Artery</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy & histology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SAR-CoV-2</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32726134</ArticleId><ArticleId IdType="doi">10.1177/1076029620936772</ArticleId><ArticleId IdType="pmc">PMC7391435</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur Heart J. 2020 Jan 21;41(4):543-603</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation><ArticleIdList><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Radiol. 2020 Jun;55(6):327-331</Citation><ArticleIdList><ArticleId IdType="pubmed">32118615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2006 Feb 7;144(3):157-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16461959</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Radiol. 2017 May;14(5):637-640</Citation><ArticleIdList><ArticleId IdType="pubmed">28284675</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Haemost. 2000 Aug;84(2):319-24</Citation><ArticleIdList><ArticleId IdType="pubmed">10959707</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2020 Jul;191:145-147</Citation><ArticleIdList><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation><ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation><ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2013 Mar;200(3):522-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23436840</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2009 Sep 17;114(12):2367-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19584396</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2017 Mar;208(3):495-504</Citation><ArticleIdList><ArticleId IdType="pubmed">27897042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2020 Aug;192:23-26</Citation><ArticleIdList><ArticleId IdType="pubmed">32405101</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Apr 23;:201561</Citation><ArticleIdList><ArticleId IdType="pubmed">32324102</ArticleId></ArticleIdList></Reference><Reference><Citation>Postgrad Med J. 2005 Jun;81(956):e3</Citation><ArticleIdList><ArticleId IdType="pubmed">15937197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 May 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation><ArticleIdList><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2020 May 14;41(19):1858</Citation><ArticleIdList><ArticleId IdType="pubmed">32227120</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation><ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2017 Jul;15(7):1251-1261</Citation><ArticleIdList><ArticleId IdType="pubmed">28671347</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):786-787</Citation><ArticleIdList><ArticleId IdType="pubmed">32212240</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Aug;296(2):E15-E25</Citation><ArticleIdList><ArticleId IdType="pubmed">32083985</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2004 Jul;77(919):623-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15238413</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2020 Jul;75(7):1730-1741</Citation><ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2020 Apr 23;:201544</Citation><ArticleIdList><ArticleId IdType="pubmed">32324103</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120</Citation><ArticleIdList><ArticleId IdType="pubmed">32172226</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagn Interv Imaging. 2020 May;101(5):321-322</Citation><ArticleIdList><ArticleId IdType="pubmed">32334995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000950 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000950 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32726134
|texte= Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32726134" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |